Melissa Helen Little

Melissa Helen Little serves as Professor in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences, while leading kidney regeneration research at reNEW. She maintains dual international appointments as Chief Scientist and Group Leader at Australia's Murdoch Children's Research Institute (MCRI) and holds an honorary position at the University of Melbourne.

Her pioneering work centers on kidney organoid technology derived from human pluripotent stem cells, with research spanning genetic kidney disease modeling (particularly NPHS2-related podocin disorders), viral pathogenesis studies using SARS-CoV-2, and protocol development for proximal tubule enhancement. She critically addresses organoid limitations through frameworks like DevKidCC for data standardization and her influential 'Organoids are not organs' review.

Analysis of her 2022-2025 publications reveals escalating focus on translational applications: maturation challenges for renal replacement therapy, Drosophila-based drug screening for podocytopathies, and computational approaches to overcome organoid variability. Her work bridges developmental biology, virology, and therapeutic development within regenerative medicine.

Key recognition includes:

• Honorary Doctorate from Leiden University, The Netherlands

Professor Little directs a globally collaborative research program with Novo Nordisk A/S, Leiden University Medical Center, and Somite Therapeutics (where she serves on the board). Her team holds patents for kidney organoid technology and maintains active industry partnerships while advancing organoid models toward clinical applications in kidney disease treatment.